Eric Skjeveland
VP, BUSINESS DEVELOPMENT at INTERNATIONAL AIDS VACCINE · NY · International
$378K
Peak Total Compensation
2
Years Tracked
5x
vs. Median Household
Eric Skjeveland has appeared in compensation disclosures over 2 years of available data (2022–2023). Total compensation changed from $331,630 to $378,110 - a 14% increase.
Peak total compensation of $378,110 equals 5x the median U.S. household income ($75,000).
Compensation History
Year-by-Year Detail
| Year | Organization | Title | Compensation | Other | Total |
|---|---|---|---|---|---|
| 2023 | INTERNATIONAL AIDS VACCINE | VP, BUSINESS DEVELOPMENT | $341,395 | $36,715 | $378,110 |
| 2022 | INTERNATIONAL AIDS VACCINE | VP, BUSINESS DEVELOPMENT | $314,481 | $17,149 | $331,630 |
Peers at INTERNATIONAL AIDS VACCINE
| Name | Title | Peak Comp. |
|---|---|---|
| Mark B Feinberg | PRESIDENT/CEO | $830K |
| Mark Feinberg | PRESIDENT/CEO | $684K |
| Ana Cespedes Montoya | CHIEF OPERATING OFFICER | $619K |
| Christopher Parks | ASS. VP, VIRAL VACC. & HEAD OF DDL | $527K |
| Swati Gupta | VP, HEAD OF EID AND EPIDEMIOLOGY | $513K |
| Labeeb Abboud | SEC. SR VP, GEN COUNS (UNTIL 7/31/21) | $470K |
| Louis D Schwartz | ASST. SEC., CHIEF FIN. & ADMIN OFF. | $467K |
| Thomas Hassell | VP, PDC (UNTIL 9/30/22) | $462K |
| Mario Gagliano | CHIEF PEOPLE OFFICER, VP OF HR | $445K |
| Dagna Laufer | VP AND HEAD OF CLINICAL DEVELOPMENT | $442K |
Email Alerts
Get notified about Eric Skjeveland
Get an email when a new IRS Form 990 filing is posted that includes this executive. We send a confirmation link first - we don't add you to any other list.
Compare with another executive: Open comparison tool →